All news

CVS declares dividend as analyst target implies 36.5% upside

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

CVS Health declared a quarterly dividend of USD 0.665 per share. The move follows a second quarter in which revenue rose 7.30% to USD 106.10 billion and adjusted earnings per share climbed 42.50%. Cantor Fitzgerald reiterated an Overweight rating and a USD 110.00 price target on the stock. The company also raised its fiscal 2026 adjusted earnings guidance, pointing to a broader recovery despite ongoing operational variables across its business segments.

Read original source

CVS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.